MedTrace Logo

The Indol Profile; Exploring the Metabolic Profile of Neuroendocrine Tumors

NCT02815969 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2024-05-06

No results posted yet for this study

Summary

This is an observational and exploratory study. Participants will be asked for a blood collection and a 24- hour collection of urine. The indol profile and levels of catecholamine and metabolites in PRP, as well as in 24- hour collection of urine will be measured with LC-MS/MS and analyzed.

Conditions

Interventions

OTHER

vena punction

vena punction and urine collection

Sponsors & Collaborators

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • A. M.E. Walenkamp, MD, PhD · University Medical Center Groningen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2019-08-31
Completion
2019-08-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02815969 on ClinicalTrials.gov